AnaptysBio
ANAB
ANAB
160 hedge funds and large institutions have $1.13B invested in AnaptysBio in 2024 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 62 increasing their positions, 31 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.29% more ownership
Funds ownership: 109.06% → 111.35% (+2.3%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
23% less call options, than puts
Call options by funds: $28.5M | Put options by funds: $36.9M
Holders
160
Holding in Top 10
2
Calls
$28.5M
Puts
$36.9M
Top Buyers
| 1 | +$20.9M | |
| 2 | +$14.7M | |
| 3 | +$13.7M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$11.5M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$10.2M |
Top Sellers
| 1 | -$12.5M | |
| 2 | -$10.2M | |
| 3 | -$8.04M | |
| 4 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
-$6.26M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$5.54M |